124 related articles for article (PubMed ID: 15274395)
1. Circulating soluble E-cadherin levels are of prognostic significance in patients with multiple myeloma.
Syrigos KN; Harrington KJ; Karayiannakis AJ; Baibas N; Katirtzoglou N; Roussou P
Anticancer Res; 2004; 24(3b):2027-31. PubMed ID: 15274395
[TBL] [Abstract][Full Text] [Related]
2. The clinical significance of soluble E-cadherin in nonsmall cell lung cancer.
Charalabopoulos K; Gogali A; Dalavaga Y; Daskalopoulos G; Vassiliou M; Bablekos G; Karakosta A; Constantopoulos S
Exp Oncol; 2006 Mar; 28(1):83-5. PubMed ID: 16614715
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of soluble adhesion molecules in Hodgkin's disease.
Syrigos KN; Salgami E; Karayiannakis AJ; Katirtzoglou N; Sekara E; Roussou P
Anticancer Res; 2004; 24(2C):1243-7. PubMed ID: 15154654
[TBL] [Abstract][Full Text] [Related]
4. Significance of the serum level of soluble E-cadherin in patients with HCC.
Soyama A; Eguchi S; Takatsuki M; Kawashita Y; Hidaka M; Tokai H; Nagayoshi S; Mochizuki S; Matsumoto S; Hamasaki K; Tajima Y; Kanematsu T
Hepatogastroenterology; 2008; 55(85):1390-3. PubMed ID: 18795696
[TBL] [Abstract][Full Text] [Related]
5. Aerodigestive tract invasion by well-differentiated thyroid carcinoma: diagnosis, management, prognosis, and biology.
McCaffrey JC
Laryngoscope; 2006 Jan; 116(1):1-11. PubMed ID: 16481800
[TBL] [Abstract][Full Text] [Related]
6. Circulating N-cadherin levels are a negative prognostic indicator in patients with multiple myeloma.
Vandyke K; Chow AW; Williams SA; To LB; Zannettino AC
Br J Haematol; 2013 May; 161(4):499-507. PubMed ID: 23438504
[TBL] [Abstract][Full Text] [Related]
7. Positive association of up-regulated Cripto-1 and down-regulated E-cadherin with tumour progression and poor prognosis in gastric cancer.
Zhong XY; Zhang LH; Jia SQ; Shi T; Niu ZJ; Du H; Zhang GG; Hu Y; Lu AP; Li JY; Ji JF
Histopathology; 2008 Apr; 52(5):560-8. PubMed ID: 18312357
[TBL] [Abstract][Full Text] [Related]
8. Soluble E-cadherin is an independent pretherapeutic factor for long-term survival in gastric cancer.
Chan AO; Chu KM; Lam SK; Wong BC; Kwok KF; Law S; Ko S; Hui WM; Yueng YH; Wong J
J Clin Oncol; 2003 Jun; 21(12):2288-93. PubMed ID: 12805328
[TBL] [Abstract][Full Text] [Related]
9. Serum insulin-like growth factor is not elevated in patients with early B-cell chronic lymphocytic leukemia but is still a prognostic factor for disease progression.
Molica S; Vitelli G; Mirabelli R; Digiesu G; Giannarelli D; Cuneo A; Ribatti D; Vacca A
Eur J Haematol; 2006 Jan; 76(1):51-7. PubMed ID: 16343271
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of serum soluble E-cadherin in colorectal carcinoma.
Okugawa Y; Toiyama Y; Inoue Y; Iwata T; Fujikawa H; Saigusa S; Konishi N; Tanaka K; Uchida K; Kusunoki M
J Surg Res; 2012 Jun; 175(2):e67-73. PubMed ID: 22277332
[TBL] [Abstract][Full Text] [Related]
11. E-cadherin mRNA expression analysis in evaluating the natural history of urothelial bladder cell carcinoma: results from a long-term follow-up study.
Cai T; Piazzini M; Nesi G; Taddei I; Sardi I; Detti B; Mondaini N; Dal Canto M; Bartoletti R
Oncol Rep; 2007 Apr; 17(4):925-30. PubMed ID: 17342338
[TBL] [Abstract][Full Text] [Related]
12. P-cadherin expression reduced in squamous cell carcinoma of the oral cavity: an indicatior of poor prognosis.
Muñoz-Guerra MF; Marazuela EG; Fernández-Contreras ME; Gamallo C
Cancer; 2005 Mar; 103(5):960-9. PubMed ID: 15685613
[TBL] [Abstract][Full Text] [Related]
13. sVE-cadherin and sCD146 serum levels in patients with multiple myeloma.
Wrobel T; Mazur G; Wolowiec D; Jazwiec B; Sowinska E; Kuliczkowski K
Clin Lab Haematol; 2006 Feb; 28(1):36-9. PubMed ID: 16430458
[TBL] [Abstract][Full Text] [Related]
14. Preoperative serum E-cadherin assay in patients with ovarian carcinoma.
Gadducci A; Ferdeghini M; Cosio S; Annicchiarico C; Ciampi B; Bianchi R; Genazzani AR
Anticancer Res; 1999; 19(1B):769-72. PubMed ID: 10216491
[TBL] [Abstract][Full Text] [Related]
15. Urinary concentrations of the soluble adhesion molecule E-cadherin and total protein in patients with bladder cancer.
Protheroe AS; Banks RE; Mzimba M; Porter WH; Southgate J; Singh PN; Bosomworth M; Harnden P; Smith PH; Whelan P; Selby PJ
Br J Cancer; 1999 Apr; 80(1-2):273-8. PubMed ID: 10390008
[TBL] [Abstract][Full Text] [Related]
16. A distinct profile of serum levels of soluble intercellular adhesion molecule-1 and intercellular adhesion molecule-3 in mycosis fungoides and Sézary syndrome.
López-Lerma I; Estrach MT
J Am Acad Dermatol; 2009 Aug; 61(2):263-70. PubMed ID: 19615537
[TBL] [Abstract][Full Text] [Related]
17. Distinctive E-cadherin and epidermal growth factor receptor expression in metastatic and nonmetastatic head and neck squamous cell carcinoma: predictive and prognostic correlation.
Muller S; Su L; Tighiouart M; Saba N; Zhang H; Shin DM; Chen Z
Cancer; 2008 Jul; 113(1):97-107. PubMed ID: 18473353
[TBL] [Abstract][Full Text] [Related]
18. E-cadherin expression in invasive non-lobular carcinoma of the breast and its prognostic significance.
Rakha EA; Abd El Rehim D; Pinder SE; Lewis SA; Ellis IO
Histopathology; 2005 Jun; 46(6):685-93. PubMed ID: 15910600
[TBL] [Abstract][Full Text] [Related]
19. Interaction between cytokines and sCD40L in patients with stable and unstable coronary syndromes.
Tousoulis D; Antoniades C; Nikolopoulou A; Koniari K; Vasiliadou C; Marinou K; Koumallos N; Papageorgiou N; Stefanadi E; Siasos G; Stefanadis C
Eur J Clin Invest; 2007 Aug; 37(8):623-8. PubMed ID: 17635572
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of receptor-binding cancer antigen expressed on SiSo cells (RCAS1) expression in relation to cadherin expression in patients with colorectal carcinoma.
Tsujitani S; Saito H; Honboh T; Ataka M; Tanida T; Makino M; Ikeguchi M
Dis Colon Rectum; 2007 Aug; 50(8):1241-9. PubMed ID: 17429708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]